Atossa Genetics Inc news

   Watch this stock
Showing stories 1 - 10 of about 92   

Articles published

ATOS 0.757 +0.027 (3.70%)
price chart
Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief ...
Company Contacts: Steven C. Quay, M.D., Ph.D. President & Chief Executive Officer Atossa Genetics Inc. Phone: (800) 351-3902 and Kyle Guse Chief Financial Officer, General Counsel and Secretary Atossa Genetics Inc. Phone: (800) 351-3902 Investor ...
Atossa Genetics, Inc. Announces Appointment of Scott Youmans as Chief ...  CNNMoney
Company Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Drops by -8.26%
Atossa Genetics Inc. (NASDAQ:ATOS) has lost 8.26% during the past week and dropped 15.63% in the last 4 weeks. The shares are however, negative as compared to the S&P 500 for the past week with a loss of 9.2%.
Company Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Drops by -2.44%
Atossa Genetics Inc. (NASDAQ:ATOS) has dropped 2.44% during the past week, however, the bigger picture is still very bullish; the shares have posted positive gains of 3.51% in the last 4 weeks.
Active Eye Catching Stocks: Plains All American Pipeline, L.P. (NYSE:PAA ...  Seneca Globe
Zacks Short Term Rating on Atossa Genetics Inc.
Research firm Zacks has rated Atossa Genetics Inc. (NASDAQ:ATOS) and has ranked it at 3, indicating that for the short term the shares are a hold.
Company Shares of Atossa Genetics Inc. (NASDAQ:ATOS) Drops by -12.76%  OTC Outlook
Atossa Genetics Announces FDA Acceptance of Its Investigational New Drug ...  MarketWatch
Atossa Genetics Inc. (NASDAQ:ATOS) Price Target Update
Atossa Genetics Inc. (NASDAQ:ATOS) stock has received a short term price target of $ 7 from 2 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $2.83.
Atossa Genetics (ATOS) Stock Declines Today on Heavy Trading Volume
"We rate ATOSSA GENETICS INC (ATOS) a SELL. This is driven by several weaknesses, which we believe should have a greater impact than any strengths, and could make it more difficult for investors to achieve positive results compared to most of the ...
Related articles »  
Atossa Genetics Inc. Provides Update on Pharmacogenetics Testing Now Offered ...
SEATTLE, WA, Dec 19, 2014 (Marketwired via COMTEX) -- Atossa Genetics Inc. ATOS, -2.67% today announced that its subsidiary, The National Reference Laboratory for Breast Health, Inc. (the NRLBH), a CLIA-certified laboratory located in Seattle, ...
Related articles »  
Atossa Genetics: Spotty Track Record And Short On Cash (ATOS)
investors were burned badly in Oct 2013 when Atossa initiated a voluntary recall of the ForeCYTE Breast Aspirator. The stock price dropped from over $5 to 2'sh instantly.
Atossa Genetics Soars On Distribution Pact With Henry Schein  Benzinga
Atossa Genetics' Laboratory Receives ISO 15189:2012 Certification
SEATTLE, WA--(Marketwired - Sep 25, 2015) - Atossa Genetics Inc. ( NASDAQ : ATOS ), a healthcare company focused on improving breast health through the development of pharmaceuticals to treat breast health conditions and through commercialization of ...
Atossa Genetics Inc. (ATOS) Adopts Poison Pill Provision
Atossa Genetics Inc. (Nasdaq: ATOS) announced that its Board of Directors has approved the adoption of a stockholder rights agreement.
Related articles »